Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CervoMed (CRVO) Other Working Capital Changes (2022 - 2025)

CervoMed's Other Working Capital Changes history spans 9 years, with the latest figure at -$278355.0 for Q3 2025.

  • For Q3 2025, Other Working Capital Changes fell 1284.54% year-over-year to -$278355.0; the TTM value through Sep 2025 reached $609638.0, up 2494.31%, while the annual FY2024 figure was $23568.0, 98.04% down from the prior year.
  • Other Working Capital Changes for Q3 2025 was -$278355.0 at CervoMed, down from $58967.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $960824.0 in Q2 2023 and bottomed at -$1.0 million in Q3 2023.
  • The 4-year median for Other Working Capital Changes is $42679.5 (2022), against an average of $210879.9.
  • The largest YoY upside for Other Working Capital Changes was 369447.69% in 2023 against a maximum downside of 237796.13% in 2023.
  • A 4-year view of Other Working Capital Changes shows it stood at $26392.0 in 2022, then soared by 2374.59% to $653093.0 in 2023, then crashed by 96.39% to $23568.0 in 2024, then crashed by 1281.07% to -$278355.0 in 2025.
  • Per Business Quant, the three most recent readings for CRVO's Other Working Capital Changes are -$278355.0 (Q3 2025), $58967.0 (Q2 2025), and $23568.0 (Q4 2024).